| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $147.9M | +70.5% |
| SG&A Expense | $43.4M | +45.5% |
| Operating Income | -$204.8M | -75.7% |
| Income Tax | -$279K | +70.6% |
| Net Income | -$198.1M | -62.6% |
| EPS (Basic) | -$2.18 | +48.0% |
| EPS (Diluted) | -$2.18 | +48.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.6M | -77.8% |
| Current Assets | $143.0M | -51.8% |
| Total Assets | $193.9M | -46.2% |
| Current Liabilities | $56.4M | +111.2% |
| Total Liabilities | $60.8M | +38.0% |
| Stockholders' Equity | $133.1M | -57.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$165.4M | -25.5% |
| Capital Expenditures | $8.7M | -45.8% |
| Investing Cash Flow | $18.7M | +139.7% |
| Financing Cash Flow | $655K | -99.6% |
| Free Cash Flow | -$174.1M | -17.7% |